¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hormone therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 4
¿µ¹® gene therapy ÇÑ±Û À¯ÀüÀÚ¿ä¹ý
¼³¸í   
  À¯Àüº´À» Ä¡·áÇÒ ¸ñÀûÀ¸·Î, Á¤»óÀûÀ¸·Î ±â´ÉÇϴ ´ÜÀÏÀ¯ÀüÀڠȤÀº º¹¼öÀ¯ÀüÀÚ¸¦ ¾î¶² ±â¿ø¿¡¼­ ¾ò¾î³»¾î »ý¼¼Æ÷¿¡ µµÀÔÇϴ °Í. À¯Àü¹°ÁúÀº À¯ÀüÀÚ»ðÀÔ Á¶ÀÛ¿¡ ÀÇÇØ ¼ö¿ë¼¼Æ÷¿¡·Î µµÀԵȴÙ. Áï, À¯ÀüÀÚ¸¦ ³¢¿ö ³ÖÀº »õ·Î¿î ¼¼Æ÷¸¦ »ç¿ëÇϴ ġ·á·Î¼­ 1980³â ¹Ì±¹ÀÇ ÇÐÀÚ°¡ ÁöÁßÇØºóÇ÷ȯÀÚ¿¡°Ô °­ÇàÇÏ¿© ºñÆÇÀ» ¹Þ¾ÒÁö¸¸, ¹Ì±¹ ±¹¸³º¸°Ç¿¬±¸¼Ò´Â 1990³â 9¿ù ¾Æµ¥³ë½Å µ¥¾Æ¹Ì³ª¾ÆÁ¦(adenosine deaminase, ADA) °áÇÌÁõ È¯ÀÚÀÇ ¸²ÇÁ±¸¿¡ ADA À¯ÀüÀÚ¸¦ ³¢¿ö ³Ö´Â Ä¡·á¸¦ ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç´Â ¾ÏÀ» Æ÷ÇÔÇÑ ¸¹Àº Áúº´µéÀ» Ä¡·áÇϴ ¸ñÀûÀ¸·Î ¾²ÀδÙ.
¿µ¹® Electric convulsive therapy(ECT) ÇÑ±Û Àü±â°æ·Ã¿ä¹ý
¼³¸í   
  ³ú¿¡ Àü±â ÀÚ±ØÀ» ÁÖ¾î ÀÎÀ§ÀûÀ¸·Î °æ·ÃÀ» À¯¹ßÇÔÀ¸·Î½á Á¤½Å º´À» Ä¡·áÇϴ ¹æ¹ý. Àü±â¼îÅ©¿ä¹ý(electroshock therapy)À̶ó°íµµ ÇÑ´Ù. 1938³â¿¡ ÀÌÅ»¸®¾ÆÀǠü¸¦·¹Æ¼¿Í ºñ´Ï¿¡ ÀÇÇØ ½ÃÀ۵Ǿú´Ù. ÀÛ¿ë±âÀüÀº È®½ÇÄ¡ ¾ÊÀ¸³ª ³úÀÇ ½ÅÁø´ë»ç, »ýÈ­ÇР¹× È¿¼Ò µî¿¡ º¯È­¸¦ ÀÏÀ¸Å²´Ù´Â »ý¹°ÇÐÀû, »ýÈ­ÇÐÀû Çм³ÀÌ À¯·ÂÇÏ´Ù.
  
  ÀûÀÀÁõÀ¸·Î °¡Àå È¿°úÀûÀΠº´Àº ¿ì¿ïÁõÀ¸·Î Æ¯È÷ ¿©¼º¿¡¼­ °»³â±â¿¡ È£¹ßÇϴ °»³â±â ¿ì¿ïÁõ, ¿ì¿ïÁõ°ú Á¶Áõ(¾ÆÁÖ ±âºÐÀÌ ÁÁÀº »óŰ¡ Áö¼ÓµÇ´Â Á¤½Åº´)ÀÌ ÀÏÁ¤ÇÑ Áֱ⸦ µÎ°í ¹Ýº¹Çϴ Á¶¿ïÁõ¿¡ Àß ¾²À̸ç, 80~90%¿¡¼­ È¿°ú°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • syndrome of inappropriate antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
  • syndrome of inappropriate antidiuretic hormone secretion
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
  • syndrome of inappropriate secretion of antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
  • sex hormone
    ¼ºÈ£¸£¸ó
  • sex hormone-binding globulin
    ¼ºÈ£¸£¸ó°áÇձ۷κҸ°
  • antibiotic therapy
    Ç×»ýÁ¦¿ä¹ý
  • acetylsalycylic acid antiplatelet therapy
    ¾Æ¼¼Æ¿»ì¸®½Ç»êÇ×Ç÷¼ÒÆÇ¿ä¹ý
  • acid therapy
    »ê¿ä¹ý
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • behavioral therapy
    Çൿ¿ä¹ý
  • biologic therapy
    »ý¹°ÇÐÀûÁ¦Á¦¿ä¹ý
  • client-centered therapy
    ³»´ãÀÚÁ߽ɿä¹ý, ÀÇ·ÚÀÎÁ߽ɿä¹ý
  • cognitive therapy
    ÀÎÁö¿ä¹ý
  • cold therapy
    ÇÑ·©¿ä¹ý, Àú¿Â¿ä¹ý
  • combined modality therapy
    º´¿ë¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • parathyroid hormone
    ºÎ°©»ó»ùÈ£¸£¸ó
  • pituitary hormone
    ³úÇϼöüȣ¸£¸ó
  • placental hormone
    ŹÝÈ£¸£¸ó
  • releasing hormone
    ºÐºñÈ£¸£¸ó, À¯¸®È£¸£¸ó
  • sex hormone
    ¼ºÈ£¸£¸ó
  • somatotropic hormone
    (¢¡growth hormone) ¼ºÀåÈ£¸£¸ó
  • steroid hormone
    ½ºÅ×·ÎÀ̵åÈ£¸£¸ó
  • synthesized hormone
    ÇÕ¼ºÈ£¸£¸ó
  • thyroid-stimulating hormone
    (¢¡thyrotropin) ¹æÆÐ»ùÀÚ±ØÈ£¸£¸ó, °©»ó»ùÀÚ±ØÈ£¸£¸ó
  • thyrotropic hormone
    (¢¡thyrotropin) ¹æÆÐ»ùÀÚ±ØÈ£¸£¸ó, °©»ó»ùÀÚ±ØÈ£¸£¸ó
  • thyrotropin-releasing hormone
    ¹æÆÐ»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó, °©»ó»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó
  • activity therapy
    Ȱµ¿¿ä¹ý
  • adaptive radiation therapy
    ÀûÀÀ¹æ»ç¼±Ä¡·á, ¼øÀÀ¹æ»ç¼±¿ä¹ý
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • microwave therapy apparatus
    ±ØÃÊ´ÜÆÄÄ¡·á±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • photodynamic therapy
    ±¤¿ªÇÐÄ¡·á
  • physical therapy
    ¹°¸®Ä¡·á,¹°¸®¿ä¹ý
  • physical therapy technician
    ¹°¸® ¿ä¹ý ±â»ç(ÚªìµèþÛöÐüÞÔ).
  • play therapy
    ³îÀÌ¿ä¹ý,³îÀÌÄ¡·á,À¯Èñ¿ä¹ý.
  • postoperative radiation therapy
    (¼ö)¼úÈĹæ»ç¼±Ä¡·á
  • preoperative radiation therapy
    (¼ö)¼úÀü ¹æ»ç¼±Ä¡·á
  • prolonged sleep therapy
    Áö¼Ó¼ö¸é¿ä¹ý, Àå±â¼ö¸é¿ä¹ý(íåÑ¢â²ØùèþÛö).
  • protein therapy
    ´Ü¹é(Áú)¿ä¹ý(¡­èþÛö).
  • proton beam therapy
    ¾çÀÚ¼±Ä¡·á
  • psychobiological therapy
    Á¤½Å»ý¹°ÇÐÀû Ä¡·á(¡­ßæÚªùÊîÜö½èþ).
  • psychosocial therapy
    Á¤½Å»çȸÀû ¿ä¹ý
  • pulmonary physical therapy
    Æó¹°¸®¿ä¹ý.
  • radioactive isotope therapy unit
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÄ¡·á±â
  • radioimmunoglobulin therapy
    ¹æ»ç¸é¿ª ±Û·Îºí¸°Ä¡·á
  • radioiodine therapy
    ¹æ»ç¼º¿Á¼Ò Ä¡·á
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • gonadotrop(h)in releasing hormone
    ¼º¼±ÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó
  • gonadotropin releasing hormone
    ¼º¼±ÀÚ±ØÈ£¸£¸ó À¯¸®(ºÐºñÀÚ±Ø)È£¸£¸ó
  • gonadotropin releasing hormone
    ¼º¼± ÀÚ±Ø È£¸£¸ó À¯¸®(ºÐºñÀÚ±Ø) È£¸£¸ó
  • gonadotropin-releasing hormone
    ¼º¼±ÀÚ±ØÈ£¸£¸óÀ¯¸®<--¹æÃâ>È£¸£¸ó
  • growth hormone
    ¼ºÀåÈ£¸£¸ó(à÷íþ¡­)
  • growth hormone
    ¼ºÀåÈ£¸£¸ó
  • growth hormone =GH
    ¼ºÀåÈ£¸£¸ó.
  • growth hormone =GH
    ¼ºÀå(à÷íþ)È£¸£¸ó.
  • growth hormone assay
    ¼ºÀåÈ£¸£¸óÃøÁ¤
  • growth hormone-releasing factor
    ¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ<--¹æÃâÀÎÀÚ>
  • hormone
    È£¸£¸ó
  • hormone antagonist
    Ç×È£¸£¸ó¾à, Ç×È£¸£¸ó¹°Áú.
  • hormone bombardment
    È£¸£¸óÃæ°ÝÅõ¿©.
  • hormone bombardment
    È£¸£¸óÃæ°Ý¿ä¹ý.
  • hormone defect (hermaphroditism)
    È£¸£¸ó°áÇÔ (¹ÝÀ½¾çÁõ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • luteotropic hormone
    ȲüÀÚ±Ø(üÜô÷í©Ð½)È£¸£¸ó
  • melanocyte-stimulating hormone
    ¸á¶ó´Ñ¼¼Æ÷ÀÚ±Ø(á¬øàí©Ð½) È£¸£¸ó
  • molting hormone
    Å»ÇÇ(÷­ù«)È£¸£¸ó
  • natriuretic hormone
    ¼Òµð¿ò¹è¼³Áõ°¡(ÛÉàÜñòÊ¥) È£¸£¸ó
  • oxytocic hormone
    ¿Á½ÃÅä½Å È£¸£¸ó
  • paracrine hormone
    ¹æºÐºñ(ÛÀÝÂÝô) È£¸£¸ó
  • parathyroid hormone
    ºÎ°©»ó¼±(ÜùË£ßÒàÍ) È£¸£¸ó
  • peptide hormone
    ÆéŸÀ̵å È£¸£¸ó
  • plant hormone
    ½Ä¹°(ãÕÚª) È£¸£¸ó
  • plant sex hormone
    ½Ä¹°(ãÕÚª) ¼º(àõ)È£¸£¸ó
  • pregnancy hormone
    ÀÓ½Å(ìõãã) È£¸£¸ó
  • prolactin regulatory hormone
    ÇÁ·Ñ¶ôƾ Á¶Àý(ðàï½)È£¸£¸ó
  • prolactin release-inhibiting hormone
    ÇÁ·Ñ¶ôƾ À¯¸®ÀúÇØ(ë´×îîÁúª)È£¸£¸ó
  • prolactoin releasing hormone
    ÇÁ·Ñ¶ôƾ À¯¸®ÀÚ±Ø(ë´×îí©Ð½)È£¸£¸ó
  • prothoracicotropic hormone
    Èä¼±ÀÚ±Ø(ýØàÍí©Ð½)È£¸£¸ó Àü±¸Ã¼(îñÏÌô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FSH-RH Follicle Stimulating Hormone Releasing Hormone
GHRH Growth Hormone Releasing Hormone
GIH Growth hormone release Inhibiting Hormone
  = Somatostatin
GRH Growth hormone Releasing Hormone
FRH follicle-stimulating hormone-releasing hormone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ART Antiretroviral therapy
ALT Autolymphocyte therapy
BMT Behavioral Marital Therapy
BNCT Boron Neutron Capture Therapy
BCT Breast Conserving Therapy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adjunctive therapy
    ºÎ°¡ ¿ä¹ý
    ÁÖµÈ Ä¡·á °úÁ¤ ÀÌ¿ÜÀÇ Ãß°¡ Ä¡·á °úÁ¤.
  • adjuvant therapy
    º¸Á¶ ¿ä¹ý
  • anticoagulant therapy
    Ç×ÀÀ°í Ä¡·á, Ç×ÀÀ°í ¿ä¹ý
  • antimicrobial therapy
    Ç×±Õ ¿ä¹ý
  • atropine therapy
    ¾ÆÆ®·ÎÇÉ Ä¡·á, ¾ÆÆ®·ÎÇÉ ¿ä¹ý
  • aversion therapy
    Çø±â¿ä¹ý
    ¿øÇÏÁö ¾Ê´Â Çൿ ÆÐÅÏÀ» ºÒÄèÇÑ Àڱذú °áºÎ½ÃŰ´Â °Í. ¶Ç´Â ¿øÇÏÁö ¾Ê´Â ÇàÀ§·ÎºÎÅÍ ºÒÄèÇÑ ÀÚ±ØÀÌ »ý±âµµ·Ï ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÑ Ä¡·á.
  • behavior therapy
    Çൿ ¿ä¹ý, Çൿ Ä¡·á
    Á¤½Å°úÀû Ä¡·á ¹æ¹ýÀÇ Çϳª. ¹«ÀǽÄÀûÀÎ ¿ä¼Ò³ª ³»ºÎ °¥µî µîÀÇ ´«¿¡ º¸ÀÌÁö ¾Ê´Â °ÍÀ» ´ë»óÀ¸·Î ÇÏ´Â °ÍÀÌ ¾Æ´Ï¶ó Á÷Á¢ °üÂûÇÒ ¼ö ÀÖ´Â ÇൿÀ» ´ë»óÀ¸·Î Ä¡·áÇÑ´Ù. ƯÁ¤ ȯ°æÀ» ¼³Á¤Çϰí À̰Ϳ¡ ´ëÇØ¼­ ¹Ù¶÷Á÷ÇÑ ÇൿÀ» ÇÏ°Ô ¸¸µé¾î º¯È­½ÃŰ°í ½ÍÀº ÇൿÀ» °íÃijª°¡´Â ¹æ¹ýÀÌ´Ù. ÇнÀ ÀÌ·ÐÀ» ½Å°æÁõÀû ÇൿÀ̳ª ºÎÀûÀÀ Çൿ µîÀÇ ÀÌ»ó Çൿ¿¡ Àû¿ëÇϰí Çൿ º¯¿ëÀ» ²ÒÇÏ·Á´Â ÀÓ»ó½É¸®ÇÐÀû Ä¡·á¹ýÀÇ ÃÑĪ.
  • biofeedback therapy
    ¹ÙÀÌ¿ÀÇǵå¹é ¿ä¹ý
  • biologic therapy
    »ý¹°ÇÐÀû Á¦Á¦ ¿ä¹ý
  • biostimulation therapy
    »ýü ÀÚ±Ø Ä¡·á, »ýü ÀÚ±Ø ¿ä¹ý
  • cognitive therapy
    ÀÎÁö Ä¡·á, ÀÎÁö ¿ä¹ý
  • cold laser therapy
    ³Ã ·¹ÀÌÀú ¿ä¹ý
    infrared laser thera
  • conformal dynamic therapy
    ÀÔü Á¶Çü µ¿Àû Ä¡·á
  • convulsive shock therapy
    °æ·Ã ¼ï ¿ä¹ý
  • corrective therapy
    ±³Á¤ ¿ä¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
gene therapy <molecular biology> Treatment of a disease caused by malfunction of a gene, by stably transfecting the cells of the organism with the normal gene.
(18 Nov 1997)
receptors, corticotropin-releasing hormone Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behaviour of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood.
(12 Dec 1998)
receptors, gastrointestinal hormone Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, pancreatic hormone Cell surface proteins that bind pancreatic hormones with high affinity and trigger intracellular changes which influence the behaviour of cells. These include receptors for glucagon (secreted by alpha cells), insulin (secreted by beta cells), somatostatin (secreted by delta cells), and pancreatic peptide (secreted by pp cells). Some of these hormones and receptors also support neurotransmission.
(12 Dec 1998)
receptors, parathyroid hormone Cell surface proteins that bind parathyroid hormone with high affinity and trigger intracellular changes which influence the behaviour of cells. Parathyroid hormone receptors on bone, kidney, and gastrointestinal cells mediate the hormone's role in calcium and phosphate homeostasis.
(12 Dec 1998)
receptors, pituitary hormone Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system.
(12 Dec 1998)
receptors, thyroid hormone Proteins, usually found in the nucleus, that specifically bind thyroid hormones and regulate DNA transcription. These proteins, termed c-erba, are activated by hormones and cause differentiation of erythroid progenitor cells which irreversibly lose proliferative potential. Thus c-erba proteins act as growth suppressors. The c-erba proteins are encoded by at least two genes, c-erba alpha and c-erba beta. Each of these has two isoforms. Mutations in the ligand-binding domain of the beta form causes thyroid hormone resistance syndrome.
(12 Dec 1998)
receptors, thyrotropin-releasing hormone Cell surface receptors that bind thyrotropin releasing hormone (trh) with high affinity and trigger intracellular changes which influence the behaviour of cells. Activated trh receptors in the anterior pituitary stimulate the release of thyrotropin (thyroid stimulating hormone, tsh). Trh receptors on neurons mediate neurotransmission by trh.
(12 Dec 1998)
parathyroid hormone <hormone> A peptide hormone of 84 amino acids (9402 D). Stimulates osteoclasts to increase blood calcium levels, the opposite effect to calcitonin.
(18 Nov 1997)
marital therapy A form of psychotherapy involving the husband and wife and directed to improving the marital relationship.
(12 Dec 1998)
marriage therapy A type of family therapy that involves both husband and wife and focuses on the marital relationship as it affects the individual personalities, behaviours, and psychopathologies of the partners; the rationale for this method is the assumption that emotional or psychopathological processes within the family structure and in the social matrix of the marriage perpetuate individual pathological personality structures, which find expression in the disturbed marriage and are aggravated by the feedback between partners.
Synonym: marital therapy.
(05 Mar 2000)
parenteral therapy Therapy introduced usually by a needle through some other route than the alimentary canal.
(05 Mar 2000)
geriatric therapy Treatment of disease in the aged.
Synonym: geriatric therapy.
(05 Mar 2000)
germ line gene therapy The repair or replacement of a defective gene within the gamete-forming tissues, which produces an inheritable change in an organisms genetic constitution.
(09 Oct 1997)
gestalt therapy A form of psychotherapy with emphasis on the interplay of organism and environment. Basic to this therapy is the development of awareness and maturity, as well as self-confidence.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á